Correlation Between Madrigal Pharmaceuticals and Exelixis
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Exelixis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Exelixis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Exelixis, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Exelixis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Exelixis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Exelixis.
Diversification Opportunities for Madrigal Pharmaceuticals and Exelixis
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Madrigal and Exelixis is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Exelixis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exelixis and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Exelixis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exelixis has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Exelixis go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Exelixis
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 2.37 times more return on investment than Exelixis. However, Madrigal Pharmaceuticals is 2.37 times more volatile than Exelixis. It trades about 0.35 of its potential returns per unit of risk. Exelixis is currently generating about 0.33 per unit of risk. If you would invest 20,248 in Madrigal Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 12,676 from holding Madrigal Pharmaceuticals or generate 62.6% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. Exelixis
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| Exelixis |
Madrigal Pharmaceuticals and Exelixis Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and Exelixis
The main advantage of trading using opposite Madrigal Pharmaceuticals and Exelixis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Exelixis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exelixis will offset losses from the drop in Exelixis' long position.The idea behind Madrigal Pharmaceuticals and Exelixis pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Exelixis vs. TG Therapeutics | Exelixis vs. Viking Therapeutics | Exelixis vs. Madrigal Pharmaceuticals | Exelixis vs. BioXcel Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |